U-18666A
Cholesterol transport inhibitor. Inhibits feline Coronavirus infection through cholesterol trafficking. Takano et al. Antiviral Res. 145:96-102, 2017, https://doi.org/10.1016/j.antiviral.2017.07.022.
- Datasheet: view or download
- Applications:Tool compound
Biochemicals & reagents
3039-71-2
1) Sexton et al (1983) Effects of 3.beta.-[2-(diethylamino)ethoxy]androst-5-en-17-one on the synthesis of cholesterol and ubiquinone in rat intestinal epithelial cell cultures. Biochemistry 22 5687 / 2) Liscum and Faust (1989) The intracellular transport of low density lipoprotein-derived cholesterol is inhibited in Chinese hamster ovary cells cultured with 3-β-[2-(diethylamino)ethoxy]androst-5-en-17-one. J.Biol.Chem. 264 11796 / 3) Cenedella, (2009) Cholesterol synthesis inhibitor U18666A and the role of sterol metabolism and trafficking in numerous pathophysiological processes: Lipids 44, 477
387.61 ∙ 36.46
Room Temperature (des.)
U18666A is an oxidosqualene reductase inhibitor (1) which inhibits the egress of cholesterol from late endosomes and lysosomes (2). This compound is also used to study Niemann-Pick disease and for assessing the importance of molecular trafficking through the lysosomal pathway in other conditions (3).